Cargando…
A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106260/ https://www.ncbi.nlm.nih.gov/pubmed/36921118 http://dx.doi.org/10.1097/CM9.0000000000002604 |
| _version_ | 1785026394264174592 |
|---|---|
| author | Zheng, Xiang Zhang, Weijie Zhou, Hua Cao, Ronghua Shou, Zhangfei Zhang, Shuwei Cheng, Ying Chen, Xuchun Ding, Chenguang Li, Ning Shi, Shaohua Zhou, Qiang Chen, Qiuyuan Chen, Gang Chen, Zheng Zhou, Peijun Hu, Xiaopeng Xue, Wujun Zhang, Xiaodong Na, Ning Wang, Wei |
| author_facet | Zheng, Xiang Zhang, Weijie Zhou, Hua Cao, Ronghua Shou, Zhangfei Zhang, Shuwei Cheng, Ying Chen, Xuchun Ding, Chenguang Li, Ning Shi, Shaohua Zhou, Qiang Chen, Qiuyuan Chen, Gang Chen, Zheng Zhou, Peijun Hu, Xiaopeng Xue, Wujun Zhang, Xiaodong Na, Ning Wang, Wei |
| author_sort | Zheng, Xiang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106260 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101062602023-04-17 A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients Zheng, Xiang Zhang, Weijie Zhou, Hua Cao, Ronghua Shou, Zhangfei Zhang, Shuwei Cheng, Ying Chen, Xuchun Ding, Chenguang Li, Ning Shi, Shaohua Zhou, Qiang Chen, Qiuyuan Chen, Gang Chen, Zheng Zhou, Peijun Hu, Xiaopeng Xue, Wujun Zhang, Xiaodong Na, Ning Wang, Wei Chin Med J (Engl) Clinical Observation Lippincott Williams & Wilkins 2023-03-05 2023-03-14 /pmc/articles/PMC10106260/ /pubmed/36921118 http://dx.doi.org/10.1097/CM9.0000000000002604 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Clinical Observation Zheng, Xiang Zhang, Weijie Zhou, Hua Cao, Ronghua Shou, Zhangfei Zhang, Shuwei Cheng, Ying Chen, Xuchun Ding, Chenguang Li, Ning Shi, Shaohua Zhou, Qiang Chen, Qiuyuan Chen, Gang Chen, Zheng Zhou, Peijun Hu, Xiaopeng Xue, Wujun Zhang, Xiaodong Na, Ning Wang, Wei A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title | A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title_full | A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title_fullStr | A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title_full_unstemmed | A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title_short | A multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| title_sort | multi-center randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients |
| topic | Clinical Observation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106260/ https://www.ncbi.nlm.nih.gov/pubmed/36921118 http://dx.doi.org/10.1097/CM9.0000000000002604 |
| work_keys_str_mv | AT zhengxiang amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangweijie amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhouhua amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT caoronghua amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT shouzhangfei amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangshuwei amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chengying amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenxuchun amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT dingchenguang amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT lining amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT shishaohua amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhouqiang amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenqiuyuan amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chengang amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenzheng amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhoupeijun amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT huxiaopeng amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT xuewujun amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangxiaodong amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT naning amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT wangwei amulticenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhengxiang multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangweijie multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhouhua multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT caoronghua multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT shouzhangfei multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangshuwei multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chengying multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenxuchun multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT dingchenguang multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT lining multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT shishaohua multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhouqiang multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenqiuyuan multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chengang multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT chenzheng multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhoupeijun multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT huxiaopeng multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT xuewujun multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT zhangxiaodong multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT naning multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients AT wangwei multicenterrandomizedcontrolledtrialtoevaluateefficacyandsafetyofearlyconversiontoalowdosecalcineurininhibitorcombinedwithsirolimusinrenaltransplantpatients |